Background: Prolyl hydroxylase inhibitors (PHI) promote stabilization of hypoxia-inducible factor-1 alpha and affect signaling cascades of inflammation and cell death. Their beneficial use in experimental models of ulcerative colitis and lung allograft rejection led us to test the effect of the PHI dimethyl oxalyl glycine (DMOG) in the pathophysiology of graft versus host disease (GVHD).
Methods: Acute GVHD was induced in lethally irradiated BALB/c mice. DMOG was administered intraperitoneally on alternate days for the first 2-weeks posttransplant, and then twice a week till day +50, while controls received vehicle only. Animals were monitored for clinical GVHD and analyzed at day +7 and at day +50.
Results: DMOG treatment of allogeneic recipients improved survival by day +50, which was associated with decreased early gut injury and serum tumor necrosis factor-α compared with allogeneic controls. DMOG treatment of allogeneic recipients resulted in increased hypoxia-inducible factor-1 alpha expression and reduced apoptosis in the terminal ileum via Fas-associated protein with death domain protein repression along with decreased T-cell infiltration. Reduced pathology in colon after DMOG treatment associates with intestinal epithelium integrity and reduced damage caused by diminished recruitment of neutrophils.
Conclusions: Taken together, we show protective effects of DMOG on early gut GVHD and improved survival in a model of allogeneic hematopoietic cell transplantation, providing the rationale for further evaluation of PHIs, in the prevention and treatment of acute GVHD.
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8139022 | PMC |
| http://dx.doi.org/10.1097/TP.0000000000003383 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Prolyl Hydroxylase Domain protein 2 (PHD2) targets Hypoxia Inducible Factor alpha subunits (HIFα) for oxygen-dependent proline hydroxylation that leads to subsequent ubiquitination and degradation of HIFα. In addition to HIF proteins, growing evidence suggested that PHD2 may exert its multifaceted function through hydroxylase-dependent or independent activities. Given the critical role of PHD2 in diverse biological processes, it is important to comprehensively identify potential PHD2 interacting proteins.
View Article and Find Full Text PDFGenetic Loss of HIF-Prolyl-Hydroxylase 1, but Not Pharmacological Inhibition, Mitigates Hepatic Fibrosis.
Am J Pathol
November 2024
Department of General, Visceral, and Transplantation Surgery, Heidelberg University, Heidelberg, Germany; Department of General, Visceral, Thoracic, and Transplantation Surgery, University of Giessen, Giessen, Germany. Electronic address:
Article Synopsis
- Liver fibrosis results from chronic liver inflammation leading to excess extracellular-matrix production by activated hepatic stellate cells (HSCs), which can lead to serious liver damage.* -
- Research on mice showed that lacking HIF-prolyl-hydroxylase 1 (PHD1) reduced liver fibrosis severity and related inflammation, while treatment with the inhibitor DMOG did not prevent fibrosis.* -
- PHD1 deficiency was linked to decreased activation of HSCs and lower expression of fibrotic and inflammatory markers, suggesting that targeted PHD1 inhibitors might be effective in managing liver fibrosis.*
Chitosan microcarriers loaded with functional drug for stimulating osteogenesis and angiogenesis in vitro.
Int J Biol Macromol
December 2024
School of Materials Science and Engineering, University of Science and Technology Beijing, Beijing 100083, China. Electronic address:
Angiogenesis-osteogenesis coupling plays important roles in bone regeneration; therefore, biomaterials capable of stimulating both osteogenesis and angiogenesis show significant influence in bone repair. Herein, chitosan (CS) microcarriers loaded with functional drug dimethyloxalylglycine (DMOG) were prepared using the emulsion phase separation and impregnation method for stimulating osteogenesis and angiogenesis. FTIR and zeta potential analyses confirmed successful DMOG loading into CS microcarriers, primarily through physical adsorption, particularly hydrogen-bond interaction.
View Article and Find Full Text PDFArticle Synopsis
- HIF-1α plays a crucial role in helping tissues adapt to low oxygen conditions and this study looks at its effects on blood vessel formation in specific surgical flaps used in rats.
- The research involved 90 male Wistar rats divided into three groups, receiving different treatments after flap surgery to measure angiogenesis, using various testing methods including x-ray angiography and histological analysis.
- Results indicated that the group treated with DMOG showed significantly increased blood vessel density and higher levels of HIF-1α and VEGF compared to the other groups, suggesting that HIF-1α enhances blood vessel growth and may improve tissue survival in these surgical procedures.
Targeting hypoxia and thrombospondin-2 in diabetic wound healing.
FASEB J
October 2024
Department of Pathology, Yale University, New Haven, Connecticut, USA.
Article Synopsis
- Impaired wound healing in diabetic patients leads to high rates of hospitalizations and lower limb amputations due to factors like high glucose levels and cell dysfunction.
- * Research shows that excess levels of the protein thrombospondin-2 (TSP2) in diabetic wounds can hinder healing, but reducing TSP2 levels through various methods improved recovery in diabetic mice.
- * A compound called DMOG, which stabilizes a key protein (HIF-1α), helped lower TSP2 levels and promote better blood vessel formation in wounds, suggesting a potential treatment strategy for improving wound healing in diabetic patients.
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!